{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:54:01Z","timestamp":1781765641290,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-02817-x","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:45:32Z","timestamp":1744861532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The prevalence and contributing factors of NSAIDs prescription among chronic kidney disease patients in primary care: a mixed methods study from Kingdom of Bahrain"],"prefix":"10.1186","volume":"26","author":[{"given":"Walaa A.","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab M.","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameera M.","family":"Awadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadak M.","family":"Aladraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen M.","family":"Haji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadok","family":"Chlif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olakunle","family":"Alonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"3","key":"2817_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.37526\/1526-744X.2022.49.3.227","volume":"49","author":"MN Clark-Cutaia","year":"2022","unstructured":"Clark-Cutaia MN, Rivera E, Iroegbu C, Arneson G, Deng R, Anastasi JK. Exploring the evidence: symptom burden in Chronic Kidney Disease. Nephrol Nurs J. 2022;49(3):227\u201340.","journal-title":"Nephrol Nurs J."},{"issue":"9","key":"2817_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/healthcare9091212","volume":"9","author":"B Alshammari","year":"2021","unstructured":"Alshammari B, Noble H, McAneney H, Alshammari F, O\u2019Halloran P. Factors associated with burden in caregivers of patients with end-stage kidney disease (A Systematic Review). Healthcare. 2021;9(9):1212.","journal-title":"Healthcare"},{"issue":"1","key":"2817_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1523-1755.2002.00432.x","volume":"62","author":"SS Khan","year":"2002","unstructured":"Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJG, Kausz AT. Health care utilization among patients with chronic kidney disease. Kidney Int. 2002;62(1):229\u201336.","journal-title":"Kidney Int"},{"issue":"3","key":"2817_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/fampra\/cms086","volume":"30","author":"P Nderitu","year":"2013","unstructured":"Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract. 2013;30(3):247\u201355.","journal-title":"Fam Pract"},{"issue":"5","key":"2817_CR5","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999;106(5):13S-24S.","journal-title":"Am J Med."},{"issue":"1","key":"2817_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ckj\/sfz054","volume":"13","author":"C Lefebvre","year":"2020","unstructured":"Lefebvre C, Hindi\u00e9 J, Zappitelli M, Platt RW, Filion KB. Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care. Clin Kidney J. 2020;13(1):63\u201371.","journal-title":"Clin Kidney J"},{"issue":"6","key":"2817_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40620-016-0352-z","volume":"30","author":"Z Heleniak","year":"2016","unstructured":"Heleniak Z, Ciepli\u0144ska M, Szychli\u0144ski T, Rychter D, Jagodzi\u0144ska K, K\u0142os A, et al. Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease. J Nephrol. 2016;30(6):781\u20136.","journal-title":"J Nephrol"},{"issue":"4","key":"2817_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ageing\/afaa057","volume":"49","author":"TM Liew","year":"2020","unstructured":"Liew TM, Lee CS, Goh SKL, Chang ZY. The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis. Age and Ageing. 2020;49(4):570\u20139.","journal-title":"Age and Ageing"},{"issue":"6","key":"2817_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3109\/0886022X.2013.801272","volume":"35","author":"U Bilge","year":"2013","unstructured":"Bilge U, Sahin G, Unluoglu I, Ipek M, Durdu M, Keskin A. Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy. Ren Fail. 2013;35(6):906\u201310.","journal-title":"Ren Fail"},{"issue":"1","key":"2817_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2296-12-70","volume":"12","author":"RJ Adams","year":"2011","unstructured":"Adams RJ, Appleton SL, Gill TK, Taylor AW, Wilson DH, Hill CL. Cause for concern in the use of non-steroidal anti-inflammatory medications in the community -a population-based study. BMC Family Practice. 2011;12(1):70.","journal-title":"BMC Family Practice"},{"issue":"1","key":"2817_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s42506-018-0005-2","volume":"94","author":"S Abd ElHafeez","year":"2019","unstructured":"Abd ElHafeez S, Hegazy R, Naga Y, Wahdan I, Sallam S. Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study. J Egypt Public Health Assoc. 2019;94(1):8.","journal-title":"J Egypt Public Health Assoc"},{"issue":"8","key":"2817_CR12","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.4103\/jfmpc.jfmpc_271_21","volume":"10","author":"A Yasky","year":"2021","unstructured":"Yasky A, Zawawi A. Characterization of potentially inappropriate medication prescriptions for the elderly in primary care and hospital settings. Journal of Family Medicine & Primary Care. 2021;10(8):3111\u20135.","journal-title":"Journal of Family Medicine & Primary Care"},{"issue":"1","key":"2817_CR13","doi-asserted-by":"publisher","first-page":"BJGPO","DOI":"10.3399\/BJGPO.2021.0208","volume":"6","author":"SX Lin","year":"2022","unstructured":"Lin SX, Phillips T, Culliford D, Edwards C, Holroyd C, Ibrahim K, et al. Characterising risk of non-steroidal anti-inflammatory drug-related acute kidney injury: a retrospective cohort study. BJGP Open. 2022;6(1):BJGPO.","journal-title":"BJGP Open"},{"issue":"1","key":"2817_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01731-x","volume":"21","author":"EP Neale","year":"2020","unstructured":"Neale EP, Middleton J, Lambert K. Barriers and enablers to detection and management of chronic kidney disease in primary healthcare: a systematic review. BMC Nephrol. 2020;21(1):1\u201317.","journal-title":"BMC Nephrol"},{"issue":"3","key":"2817_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/jcm9030783","volume":"9","author":"WM Bezabhe","year":"2020","unstructured":"Bezabhe WM, Kitsos A, Saunder T, Peterson GM, Bereznicki LR, Wimmer BC, et al. Medication prescribing quality in australian primary care patients with chronic kidney disease. J Clin Med. 2020;9(3):783.","journal-title":"J Clin Med"},{"issue":"8","key":"2817_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.22454\/FamMed.2020.147410","volume":"52","author":"J Whitner","year":"2020","unstructured":"Whitner J, Fabiili N, Siewart J, Akasaka K, Nelson A. Pharmacist-Led provider education on inappropriate NSAID prescribing rates. Fam Med. 2020;52(8):592\u20136.","journal-title":"Fam Med"},{"issue":"13","key":"2817_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2147\/JPR.S247781","volume":"3","author":"KY Ho","year":"2020","unstructured":"Ho KY, Cardosa MS, Chaiamnuay S, Hidayat R, Ho HQT, Kamil O, et al. Practice Advisory on the Appropriate Use of NSAIDs in Primary Care. J Pain Res. 2020;3(13):1925\u201339.","journal-title":"J Pain Res"},{"issue":"4","key":"2817_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","volume":"76","author":"M Baker","year":"2020","unstructured":"Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? Am J Kidney Dis. 2020;76(4):546\u201357.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2817_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0258414","volume":"16","author":"A Avalos-Mejia","year":"2021","unstructured":"Avalos-Mejia A, Garc\u00eda-Cruz JC, Escobedo de la Pe\u00f1a J, Garrido-Acosta O, Ju\u00e1rez-Cedillo T. Reduction of inappropriate prescriptions in older adults through the support of Asynchronous Geriatric Counseling Online (AGAlink): Implemented in primary care. PLoS ONE. 2021;16(11):1\u201312.","journal-title":"PLoS ONE"},{"key":"2817_CR20","doi-asserted-by":"crossref","unstructured":"Bahrain. 2015. Available at: https:\/\/www.healthdata.org\/bahrain. Accessed 18 Jul 2022.","DOI":"10.18356\/42de6003-en"},{"key":"2817_CR21","unstructured":"Kidney Disease in United Kingdom. Available at: https:\/\/www.worldlifeexpectancy.com\/united-kingdom-kidney-disease. Accessed 18 Jul 2022."},{"key":"2817_CR22","unstructured":"KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013. Available from: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf. Accessed 5 Oct 2024."},{"key":"2817_CR23","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.02.001","volume":"79","author":"KL Johansen","year":"2022","unstructured":"Johansen KL, Chertow GM, Gilbertson DT, Herzog CA, Ishani A, Israni AK, et al. US renal data system 2021 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022;79:A8\u201312.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2817_CR24","doi-asserted-by":"publisher","first-page":"e89072","DOI":"10.1371\/journal.pone.0089072","volume":"9","author":"Y Ingrasciotta","year":"2014","unstructured":"Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, Tari DU, et al. The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy. PLoS ONE. 2014;9(2):e89072.","journal-title":"PLoS ONE"},{"issue":"14","key":"2817_CR25","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3390\/jcm10143039","volume":"10","author":"C Ortega-Loubon","year":"2021","unstructured":"Ortega-Loubon C, Mart\u00ednez-Paz P, Garc\u00eda-Mor\u00e1n E, Tamayo-Velasco \u00c1, L\u00f3pez-Hern\u00e1ndez FJ, Jorge-Monjas P, Tamayo E. Genetic Susceptibility to Acute Kidney Injury. J Clin Med. 2021;10(14):3039. https:\/\/doi.org\/10.3390\/jcm10143039. PMID: 34300206; PMCID: PMC8307812.","journal-title":"J Clin Med."},{"key":"2817_CR26","doi-asserted-by":"publisher","first-page":"110838","DOI":"10.1016\/j.cbi.2023.110838","volume":"388","author":"A D\u017eidi\u0107-Krivi\u0107","year":"2024","unstructured":"D\u017eidi\u0107-Krivi\u0107 A, Sher EK, Kusturica J, Farhat EK, Nawaz A, Sher F. Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies. Chem Biol Interact. 2024;388:110838. https:\/\/doi.org\/10.1016\/j.cbi.2023.110838.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"2817_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-15-70","volume":"15","author":"L Samal","year":"2014","unstructured":"Samal L, Linder JA, Bates DW, Wright A. Electronic problem list documentation of chronic kidney disease and quality of care. BMC Nephrol. 2014;15(1):1\u201315.","journal-title":"BMC Nephrol"},{"issue":"11","key":"2817_CR28","doi-asserted-by":"publisher","first-page":"1397160","DOI":"10.3389\/fmed.2024.1397160.PMID:39055699;PMCID:PMC11269154","volume":"11","author":"L Muglia","year":"2024","unstructured":"Muglia L, Di Dio M, Filicetti E, Greco GI, Volpentesta M, Beccacece A, Fabbietti P, Lattanzio F, Corsonello A, Gembillo G, Santoro D, Soraci L. Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis. Front Med (Lausanne). 2024;11(11):1397160. https:\/\/doi.org\/10.3389\/fmed.2024.1397160.PMID:39055699;PMCID:PMC11269154.","journal-title":"Front Med (Lausanne)"},{"issue":"597","key":"2817_CR29","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.3399\/bjgp12X636047","volume":"62","author":"NJ McIntyre","year":"2012","unstructured":"McIntyre NJ, Fluck R, McIntyre C, Taal M. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract. 2012;62(597):e227\u201332.","journal-title":"Br J Gen Pract"},{"issue":"10","key":"2817_CR30","doi-asserted-by":"publisher","first-page":"205435812211496","DOI":"10.1177\/20543581221149621","volume":"18","author":"MJ Armstrong","year":"2023","unstructured":"Armstrong MJ, Zhang K, Ye F, Klarenbach SW, Pannu NI. Population-Based Analysis of Nonsteroidal Anti-inflammatory Drug Prescription in Subjects With Chronic Kidney Disease. Can J Kidney Health Dis. 2023Jan;18(10):20543581221149620.","journal-title":"Can J Kidney Health Dis"},{"issue":"708","key":"2817_CR31","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.3399\/BJGP.2020.0871","volume":"71","author":"C MacRae","year":"2021","unstructured":"MacRae C, Mercer S, Guthrie B. Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort. Br J Gen Pract. 2021;71(708):e483\u201390.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"2817_CR32","first-page":"520","volume":"23","author":"SC Weddle","year":"2017","unstructured":"Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS. Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the Elderly. J Manag Care Spec Pharm. 2017;23(5):520\u20134.","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"2817_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5694\/j.1326-5377.2009.tb02349.x","volume":"190","author":"DW Johnson","year":"2009","unstructured":"Johnson DW, Jones GRD, Becker GJ, Mathew TH. Automated reporting of eGFR: a useful tool for identifying and managing kidney disease. Med J Aust. 2009;190(4):200\u20133.","journal-title":"Med J Aust."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02817-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-02817-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02817-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:45:37Z","timestamp":1744861537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-02817-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2817"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-02817-x","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the quantitative part: the confidentiality of the patients and their personal information will not be disclosed. All data collectors and researchers signed a form that commits them to withhold sharing any patient information. Informed consent was obtained from all participants and their legal representatives.For the qualitative part: oral consent was taken from the participating physicians, and they were informed about the study aims and objectives. They remained anonymous and their participation in the study was voluntary and they can withdraw if they wish to do so at any point. They were informed that the interviews would be recorded.Ethical approval was taken from the research and ethics committee at Arabian Gulf University (E06-PI- 11\u201322).It is unlikely that any form of harm (psychological, social, physical, legal) will come to the participating parties as none of their personal information will be revealed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}